In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 7th, 2004 | 20 | Yes |
Popular Name: Kenpaullone Kenpaullone
Find On: PubMed — Wikipedia — Google
CAS Numbers: 142273-20-9 , [142273-20-9]
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.72 | 7.21 | -9.5 | 2 | 3 | 0 | 45 | 327.181 | 0 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Purity | >95% | Fluorochem |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CCNA2-1-E | Cyclin A2 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 780 | 0.43 | Binding ≤ 10μM |
CCNB1-1-E | G2/mitotic-specific Cyclin B1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 400 | 0.45 | Binding ≤ 10μM |
CCNB2-1-E | G2/mitotic-specific Cyclin B2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 400 | 0.45 | Binding ≤ 10μM |
CCNB3-1-E | G2/mitotic-specific Cyclin B3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 400 | 0.45 | Binding ≤ 10μM |
CCNT1-1-E | Cyclin T1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 64 | 0.50 | Binding ≤ 10μM |
CDK1-1-E | Cyclin-dependent Kinase 1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 400 | 0.45 | Binding ≤ 10μM |
CDK2-1-E | Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic | Eukaryotes | 780 | 0.43 | Binding ≤ 10μM |
CDK9-1-E | Cyclin-dependent Kinase 9 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 64 | 0.50 | Binding ≤ 10μM |
GSK3A-1-E | Glycogen Synthase Kinase-3 Alpha (cluster #1 Of 3), Eukaryotic | Eukaryotes | 23 | 0.53 | Binding ≤ 10μM |
GSK3B-1-E | Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic | Eukaryotes | 230 | 0.46 | Binding ≤ 10μM |
LCK-1-E | Tyrosine-protein Kinase LCK (cluster #1 Of 4), Eukaryotic | Eukaryotes | 470 | 0.44 | Binding ≤ 10μM |
MK01-1-E | Mitogen-activated Protein Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 9000 | 0.35 | Binding ≤ 10μM |
Z104294-1-O | Cyclin-dependent Kinase 5/CDK5 Activator 1 (cluster #1 Of 2), Other | Other | 850 | 0.42 | Binding ≤ 10μM |
Z104296-1-O | Cyclin-dependent Kinase 1/cyclin B1 (cluster #1 Of 2), Other | Other | 400 | 0.45 | Binding ≤ 10μM |
Z50425-3-O | Plasmodium Falciparum (cluster #3 Of 22), Other | Other | 4000 | 0.38 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CCNA2_HUMAN | P20248 | Cyclin A2, Human | 780 | 0.43 | Binding ≤ 1μM |
CCNT1_HUMAN | O60563 | Cyclin T1, Human | 64 | 0.50 | Binding ≤ 1μM |
CDK1_HUMAN | P06493 | Cyclin-dependent Kinase 1, Human | 400 | 0.45 | Binding ≤ 1μM |
Z104296 | Z104296 | Cyclin-dependent Kinase 1/cyclin B1 | 400 | 0.45 | Binding ≤ 1μM |
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 780 | 0.43 | Binding ≤ 1μM |
Z104294 | Z104294 | Cyclin-dependent Kinase 5/CDK5 Activator 1 | 1000 | 0.42 | Binding ≤ 1μM |
CDK9_HUMAN | P50750 | Cyclin-dependent Kinase 9, Human | 64 | 0.50 | Binding ≤ 1μM |
CCNB1_HUMAN | P14635 | G2/mitotic-specific Cyclin B1, Human | 400 | 0.45 | Binding ≤ 1μM |
CCNB2_HUMAN | O95067 | G2/mitotic-specific Cyclin B2, Human | 400 | 0.45 | Binding ≤ 1μM |
CCNB3_HUMAN | Q8WWL7 | G2/mitotic-specific Cyclin B3, Human | 400 | 0.45 | Binding ≤ 1μM |
GSK3A_HUMAN | P49840 | Glycogen Synthase Kinase-3 Alpha, Human | 23 | 0.53 | Binding ≤ 1μM |
GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 23 | 0.53 | Binding ≤ 1μM |
LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 470 | 0.44 | Binding ≤ 1μM |
CCNA2_HUMAN | P20248 | Cyclin A2, Human | 780 | 0.43 | Binding ≤ 10μM |
CCNT1_HUMAN | O60563 | Cyclin T1, Human | 64 | 0.50 | Binding ≤ 10μM |
CDK1_HUMAN | P06493 | Cyclin-dependent Kinase 1, Human | 400 | 0.45 | Binding ≤ 10μM |
Z104296 | Z104296 | Cyclin-dependent Kinase 1/cyclin B1 | 400 | 0.45 | Binding ≤ 10μM |
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 780 | 0.43 | Binding ≤ 10μM |
Z104294 | Z104294 | Cyclin-dependent Kinase 5/CDK5 Activator 1 | 1000 | 0.42 | Binding ≤ 10μM |
CDK9_HUMAN | P50750 | Cyclin-dependent Kinase 9, Human | 64 | 0.50 | Binding ≤ 10μM |
CCNB1_HUMAN | P14635 | G2/mitotic-specific Cyclin B1, Human | 400 | 0.45 | Binding ≤ 10μM |
CCNB2_HUMAN | O95067 | G2/mitotic-specific Cyclin B2, Human | 400 | 0.45 | Binding ≤ 10μM |
CCNB3_HUMAN | Q8WWL7 | G2/mitotic-specific Cyclin B3, Human | 400 | 0.45 | Binding ≤ 10μM |
GSK3A_HUMAN | P49840 | Glycogen Synthase Kinase-3 Alpha, Human | 23 | 0.53 | Binding ≤ 10μM |
GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 23 | 0.53 | Binding ≤ 10μM |
MK01_HUMAN | P28482 | MAP Kinase ERK2, Human | 9000 | 0.35 | Binding ≤ 10μM |
LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 470 | 0.44 | Binding ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 10000 | 0.35 | Functional ≤ 10μM |
Description | Species |
---|---|
Activation of ATR in response to replication stress | |
Activation of NIMA Kinases NEK9, NEK6, NEK7 | |
Activation of the AP-1 family of transcription factors | |
Activation of the pre-replicative complex | |
Advanced glycosylation endproduct receptor signaling | |
AKT phosphorylates targets in the cytosol | |
APC truncation mutants have impaired AXIN binding | |
APC/C:Cdc20 mediated degradation of Cyclin B | |
AXIN missense mutants destabilize the destruction complex | |
Beta-catenin phosphorylation cascade | |
CD28 co-stimulation | |
CD28 dependent PI3K/Akt signaling | |
CD28 dependent Vav1 pathway | |
CDK-mediated phosphorylation and removal of Cdc6 | |
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | |
Condensation of Prometaphase Chromosomes | |
Condensation of Prophase Chromosomes | |
Constitutive PI3K/AKT Signaling in Cancer | |
CREB phosphorylation through the activation of Ras | |
CRMPs in Sema3A signaling | |
CTLA4 inhibitory signaling | |
Cyclin A/B1 associated events during G2/M transition | |
Cyclin A:Cdk2-associated events at S phase entry | |
Cyclin B2 mediated events | |
Cyclin E associated events during G1/S transition | |
DAP12 signaling | |
Degradation of beta-catenin by the destruction complex | |
Depolymerisation of the Nuclear Lamina | |
disassembly of the destruction complex and recruitment of AXIN to the membrane | |
DNA Damage/Telomere Stress Induced Senescence | |
Downstream TCR signaling | |
E2F mediated regulation of DNA replication | |
E2F-enabled inhibition of pre-replication complex formation | |
ERK/MAPK targets | |
ERK1 activation | |
ERK2 activation | |
ERKs are inactivated | |
Factors involved in megakaryocyte development and platelet production | |
FCERI mediated MAPK activation | |
Formation of HIV elongation complex in the absence of HIV Tat | |
Formation of HIV-1 elongation complex containing HIV-1 Tat | |
Formation of RNA Pol II elongation complex | |
G0 and Early G1 | |
G1/S-Specific Transcription | |
G2 Phase | |
G2/M DNA replication checkpoint | |
Gastrin-CREB signalling pathway via PKC and MAPK | |
Generation of second messenger molecules | |
Golgi Cisternae Pericentriolar Stack Reorganization | |
GPVI-mediated activation cascade | |
Growth hormone receptor signaling | |
HIV elongation arrest and recovery | |
Interactions of Tat with host cellular proteins | |
Interleukin-2 signaling | |
Loss of Nlp from mitotic centrosomes | |
Loss of proteins required for interphase microtubule organization from the ce | |
MASTL Facilitates Mitotic Progression | |
Meiotic recombination | |
misspliced GSK3beta mutants stabilize beta-catenin | |
NCAM signaling for neurite out-growth | |
Nef and signal transduction | |
Nef Mediated CD4 Down-regulation | |
Negative regulation of FGFR signaling | |
Nuclear Pore Complex (NPC) Disassembly | |
Oncogene Induced Senescence | |
Orc1 removal from chromatin | |
Oxidative Stress Induced Senescence | |
p53-Dependent G1 DNA Damage Response | |
Pausing and recovery of HIV elongation | |
Pausing and recovery of Tat-mediated HIV elongation | |
PD-1 signaling | |
PECAM1 interactions | |
phospho-PLA2 pathway | |
Phosphorylation of CD3 and TCR zeta chains | |
Phosphorylation of Emi1 | |
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 | |
Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 com | |
Phosphorylation of the APC/C | |
PIP3 activates AKT signaling | |
Polo-like kinase mediated events | |
Recruitment of mitotic centrosome proteins and complexes | |
Recruitment of NuMA to mitotic centrosomes | |
Recycling pathway of L1 | |
Regulation of actin dynamics for phagocytic cup formation | |
Regulation of APC/C activators between G1/S and early anaphase | |
Regulation of HSF1-mediated heat shock response | |
Regulation of KIT signaling | |
Regulation of PLK1 Activity at G2/M Transition | |
Resolution of Sister Chromatid Cohesion | |
RNA Polymerase II Pre-transcription Events | |
RNA Polymerase II Transcription Elongation | |
RSK activation | |
S33 mutants of beta-catenin aren't phosphorylated | |
S37 mutants of beta-catenin aren't phosphorylated | |
S45 mutants of beta-catenin aren't phosphorylated | |
SCF(Skp2)-mediated degradation of p27/p21 | |
Senescence-Associated Secretory Phenotype (SASP) | |
Signal attenuation | |
Signal transduction by L1 | |
Signaling by FGFR | |
Signaling by SCF-KIT | |
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | |
T41 mutants of beta-catenin aren't phosphorylated | |
Tat-mediated elongation of the HIV-1 transcript | |
Tat-mediated HIV elongation arrest and recovery | |
Thrombin signalling through proteinase activated receptors (PARs) | |
Translocation of ZAP-70 to Immunological synapse | |
truncations of AMER1 destabilize the destruction complex | |
XBP1(S) activates chaperone genes |
No pre-computed analogs available. Try a structural similarity search.